Clinical trial
A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia FX-635 on Low Back Pain
NCT02538523 is registered in ClinicalTrials.gov with Erchonia Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia FX-635 on Low Back Pain
- Lead sponsor
- Erchonia Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 8, 2016
- Completion date
- December 10, 2017
- Enrollment
- 58 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.